Kriya Announces Gene Therapy Program for Thyroid Eye Disease
05. Januar 2024 09:00 ET
|
Kriya Therapeutics, Inc.
– KRIYA-586 is designed to be a one-time treatment delivered by focal peribulbar injection, that encodes an antibody blocking the Insulin-Like Growth Factor 1 Receptor (IGF-1R), a clinically validated...